Integrated research compliance solutions to streamline your study
Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.
Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.
Our Latest Updates
Discover What’s Happening at Advarra
NIH OSP has revised the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to eliminate duplicative regulatory oversight.
Experts Rebecca Miksad and Tim Stoddard of Flatiron Health provide a practical look at the role of real-world evidence (RWE) in regulatory, drug development, and clinical decision-making.
Questions still remain about GDPR and its applications. Have you considered these six key questions to ask within your organization?
May 21-23, 2019
New Orleans, LA